Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05986890 · ClinicalTrials.gov registry record · NA
Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction
A NA study of Malignant Gastric Outlet Obstruction, sponsored by Corewell Health West.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT05986890 is a NA study of Malignant Gastric Outlet Obstruction that is actively recruiting participants, run by Corewell Health West. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05986890, a NA study of Malignant Gastric Outlet Obstruction, is actively recruiting participants, sponsored by Corewell Health West.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is intended to investigate whether roux-en-y bypass surgery is superior to conventional loop gastrojejunostomy for Malignant gastric outlet obstruction in terms of tolerance to solid food intake. We hypothesize that roux-en-y bypass will be associated with improved solid food intake in the first 30 days after surgery.
Conditions Studied
Interventions
- PROCEDURE Roux-en-Y Bypass
- PROCEDURE gastrojejunostomy
Study Locations (1)
Michigan
- G. Paul Wright - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-08-17 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05986890
The ClinicalTrials.gov registry entry for NCT05986890 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Gastric Outlet Obstruction appearing as the primary indexed condition, and to 2 interventions - of which Roux-en-Y Bypass is the first listed.
NCT05986890 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05986890 about?
NCT05986890 is a clinical study titled "Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction". This study is intended to investigate whether roux-en-y bypass surgery is superior to conventional loop gastrojejunostomy for Malignant gastric outlet obstruction in terms of tolerance to solid food intake. We hypothesize that roux-en-y bypass will be associated with improved solid food intake in th...
What is the current status of trial NCT05986890?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2023-08-17. Estimated completion is 2026-12-01.
What conditions does trial NCT05986890 study?
This clinical trial studies the following conditions: Malignant Gastric Outlet Obstruction.
What interventions are being tested in trial NCT05986890?
The interventions under investigation include: Roux-en-Y Bypass (PROCEDURE), gastrojejunostomy (PROCEDURE).
Who is sponsoring clinical trial NCT05986890?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05986890 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Gastric Outlet Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.